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Role of carbonic anhydrases in skin wound healing
Harlan Barker1,5, Marleena Aaltonen1,5, Peiwen Pan1, Maria Vähätupa1, Pirkka Kaipiainen1, Ulrike May1,
Stuart Prince1, Hannele Uusitalo-Järvinen1,2, Abdul Waheed3, Silvia Pastoreková4, William S Sly3,
Seppo Parkkila1,2 and Tero AH Järvinen1,2
Skin wound closure occurs when keratinocytes migrate from the edge of the wound and re-epithelialize the epidermis. Their
migration takes place primarily before any vascularization is established, that is, under hypoxia, but relatively little is known
regarding the factors that stimulate this migration. Hypoxia and an acidic environment are well-established stimuli for cancer cell
migration. The carbonic anhydrases (CAs) contribute to tumor cell migration by generating an acidic environment through the
conversion of carbon dioxide to bicarbonate and a proton. On this basis, we explored the possible role of CAs in tissue
regeneration using mouse skin wound models. We show that the expression of mRNAs encoding CA isoforms IV and IX are
increased (~25× and 4× , respectively) during the wound hypoxic period (days 2–5) and that cells expressing CAs form a band-
like structure beneath the migrating epidermis. RNA-Seq analysis suggested that the CA IV-speciﬁc signal in the wound is
mainly derived from neutrophils. Due to the high level of induction of CA IV in the wound, we treated skin wounds locally with
recombinant human CA IV enzyme. Recombinant CA IV signiﬁcantly accelerated wound re-epithelialization. Thus, CA IV could
contribute to wound healing by providing an acidic environment in which the migrating epidermis and neutrophils can survive
and may offer novel opportunities to accelerate wound healing under compromised conditions.
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INTRODUCTION
The healing of a human skin wound is a complex and
highly coordinated biological process that involves diverse
phenomena such as hemostasis, inﬂammation, re-epithelializa-
tion, angiogenesis, ﬁbroplasia and ﬁnally tissue remodeling.1,2
‘Re-epithelialization’ is the lateral migration of keratinocytes
across a wound bed, which when successful, closes the
wound.1,2
Re-epithelialization begins within hours after injury. It is
believed that a critical switch for the initiation of keratinocyte
migration is the acute change in oxygen tension.1 That is,
when the skin is wounded and the dermal blood vessels are
clotted and no longer able to deliver oxygen to the
skin, the keratinocytes experience the stress of acute hypoxia
and initiate migration to close the defect. Remarkably,
the re-epithelialization takes place mainly under hypoxia,
and wound closure can be completed before any new
re-vascularization occurs.1
Studies have shown that in addition to hypoxia, acidosis
stimulates cancer cell migration.3,4 Carbonic anhydrases (CA)
are a family of zinc metalloenzymes that regulate the
tissue acid–base equilibrium by catalyzing the reversible
hydration of carbon dioxide to bicarbonate ions and protons
(CO2+H2Oo–4HCO3−+H+).3–5 Fifteen human CA isoforms
have been found, of which 12 are active and 3 inactive.6,7 These
isoenzymes are expressed to some extent in all tissues and
organs, but particularly in those that are metabolically highly
active such as the brain and kidney.3,5 Interestingly, the
expression of CA proteins IX and XII is induced by hypoxia
in different tumors.8 Through their ability to regulate pH and
generate an acidic environment, these enzymes endow tumor
cells with survival advantages under hypoxia/acidosis condi-
tions and confer an increased ability to migrate.
The potency of the CAs, IX and XII, to stimulate cell
migration under hypoxia prompted us to investigate the role of
CAs in skin wound healing. Quite unexpectedly, nothing is
known regarding CAs during skin wound healing, although the
restoration of CA activity is related to duodenal ulcers. We
assumed that the expression of certain CA family members
could increase when a wound is exposed to hypoxia and,
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theoretically, could stimulate re-epithelialization by generating
an acidic environment for keratinocytes. Thus, we studied the
expression pattern of the enzymatically active CAs in wounds
in mice, and based on the results also treated the wounds with
exogenous recombinant CA IV enzyme.
MATERIALS AND METHODS
Generation of skin wounds
For the quantitative PCR (qPCR) and immunohistochemistry
analyses, 8-week-old male BALB/c mice (weighing 23–25 g) were
used. Mice were fed with standard laboratory pellets and water
ad libitum. All animal experiments were performed in accordance
with protocols approved by the National Animal Ethics Committee of
Finland.
Six-millimeter diameter, full thickness (including panniculus carnosus
muscle) excision wounds were created in the dorsal skin under
sevoﬂurane anesthesia as previously described.9 At various time points,
the animals were killed, and the wounded tissue was collected and
processed for further analyses.
qPCR analysis
Total skin wound RNA collected at various time points was converted
to cDNA by reverse transcription using the High Capacity
cDNA Reverse Transcription Kit for RT-qPCR (Applied Biosytems,
Foster City, CA, USA). Duplicate qRT-PCR reactions were performed
with PowerSYBR SYBRGreen reagents (Applied Biosytems) on an
ABI 7000 Real Time PCR System (Applied Biosytems). Details of the
primers used are listed in Supplementary Table 1. As negative controls,
no-template and no-reverse transcriptase controls were also included
(which were negative herein). The data analyses were performed
according to Livak and Schmittgen.10
Expression and puriﬁcation of recombinant human CA IV
cDNA for the secretory form of human CA IV was cloned in pET-11d,
a bacterial expression vector, as previously described.11 Brieﬂy, the
E. coli strain Rosetta(DE3)pLysS was used for enzyme production.
The enzyme was puriﬁed using a CA-inhibitor afﬁnity column.11
Afﬁnity-puriﬁed enzyme was dialyzed against 20 mM ammonium
bicarbonate for several changes of buffer. Endotoxin removal was
performed using a specialized endotoxin removal column three times
(Hyglos Blue Endotoxin Removal Column, Starnberg, Germany). The
protein samples were then re-dialyzed with saline, ﬁlter-sterilized and
stored at 4 °C. Recombinant CA IV was analyzed on an NuPAGE 4–
12% gradient gel (ThermoFisher Scientiﬁc, Waltham, MA, USA). The
enzymatic activity of recombinant CA IV was assayed as previously
described.11
Skin wound treatment trial with recombinant CA IV
For the treatment trial, 8-week-old male littermate BALB/c mice were
used. Two 6-mm, circular, full-thickness wounds were generated in
each animal by biopsy punch. Donut-shaped 12-mm silicone splints
(Grace Bio-Labs, Bend, OR, USA) were placed around the wounds
and afﬁxed with glue and sutures to prevent wound contraction.12
Plastic collars were used to prevent the mice from tearing off the
splints.12 The mice that underwent surgery were divided into three
groups. The ﬁrst group consisted of mice treated with CA IV; puriﬁed
CA IV was mixed with 30% Pluronic-127 (Sigma-Aldrich) gel as
previously described,13 and the pH was 7.0. Fifty microliters of the
mixture was added to each wound to ﬁll up the entire wound cavity.
The second group received a CA inhibitor, acetazolamide (1.0 mM,
Orion, Espoo, Finland), in Pluronic-127 gel. The third group served as
a control group and was treated with 50 μl of phosphate-buffered
saline mixed with Pluronic-127 gel. The ﬁnal concentration of
Pluronic-127 in each solution was 18%. Each mouse was photo-
graphed after the silicone splints had been securely sutured in place
and then killed on day 5.
RNA-Seq analysis of wound-speciﬁc tissues
RNA-Seq data from human B-cells, CD4-positive cells, CD8-positive
cells, monocytes, neutrophils, natural killer (NK) cells, monocytes
(ArrayExpress accession E-GEOD-60424),14 dermal ﬁbroblasts
(E-GEOD-72589), undifferentiated and differentiated keratinocytes
(E-MTAB-1717),15 M1 and M2 macrophages (E-GEOD-36952), and
skin cells (E-MTAB-2836)16 were retrieved from the Array Express
database. Reads for all samples were pooled by tissue type and mapped
to CA genes in the human genome using the Bowtie17 and Tophat18
modules of the Tophat package utilizing supercomputer resources
provided by CSC–IT Center for Science of the Finnish Ministry of
Education and Culture. Subsequent matches were then compared to
reference CA transcript structures from the Ensembl database using
the Cuffcompare module of the Cufﬂinks package.19 Normalized
fragments per kilobase of transcript per million mapped read (FPKM)
values were generated for each transcript identiﬁed in each tissue using
the Cuffnorm module of the Cufﬂinks package to compare expression
values across the pooled samples. The expression levels of each
CA were compared across tissue types using the Cuffmerge and
Cuffdiff modules of Cufﬂinks. The results were visualized using the
cummeRbund R library.
Statistical analysis
The data are presented as the mean± s.d. For comparisons of multiple
groups, statistical analysis was conducted by two-way analysis of
variance complemented by the Bonferroni post hoc test for pair wise
comparisons between the test groups. P-valueso0.05 were considered
signiﬁcant.
Supplementary Methods
Extraction of RNA, the oxygen-induced retinopathy model,
immunohistochemistry, histology, quantitative analysis of histology
(wound healing), promoter analysis of the primary CA4 (human gene
for CA IV protein) transcript and gene ontology (GO) analysis of
proteins were performed using standard methods20–24 and are
described in detail in the Supplementary Data set.
RESULTS
Expression of CA IV and CA IX is induced during the
hypoxic phase of wound healing
To investigate the role of CAs in the skin wound healing
process, we determined the expression pattern of 11 active
members of the CA family (CA I, II, III, IV, Vb, VI, VII, IX,
XII, XIII and XV) by qPCR analysis of wounds at different
stages of healing, and compared their expression to the levels
observed in normal, unwounded skin. Hypoxia persisted in our
excision wound model for 5 days after wounding, after which
extensive angiogenesis vascularized the wound bed.9 Among
the CA family members, the expression of CA IV mRNA was
induced most strongly at almost 25-fold above normal 2 days
after the wounding and remained elevated more than 5-fold at
5 days after wounding (Figure 1). CA IX was the only other
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enzyme that showed elevated expression during wound healing;
its expression peaked at 3 days to a level more than fourfold
that of normal skin and remained elevated after day 5 of
healing (Figure 1). After the skin wound was vascularized
(from day 5 on), none of the CAs showed any enhanced
expression at the mRNA level (Figure 1).
As CAs IV and IX showed increased mRNA expression
during the hypoxic phase of wound healing, we decided to
explore their expression in detail by immunohistochemistry.
CA IV protein expression started to accumulate in early
granulation tissue at day 5 after healing and remained positive
in the wound until day 10, after which the expression
disappeared (Figure 2). CA IV protein was expressed mainly
by cells in granulation tissue with especially strong, band-like,
expression just beneath the migrating epidermis (Figure 2).
CA IX protein expression, in turn, was already observed in the
skin wound at day 2 and remained elevated throughout the
wound healing process, that is, after CA IV had disappeared
from the wound tissue (Figure 2). Both the epidermis and
underlying granulation tissue expressed CA IX, but the
strongest CA IX protein expression was also observed in the
migrating epidermis and just beneath the migrating epidermis
in the top layer of the dermis (Figure 2).
CA transcripts in wound-related cells
To elucidate the cell sources that produce CAs during wound
healing, a thorough analysis of human RNA-Seq data was
performed. RNA-Seq analysis of 12 cell types and tissues
revealed that a CA4 transcript was signiﬁcantly expressed
only in skin and neutrophils (Figure 3). In both tissues,
only the 312-amino-acid ENST00000300900 CA4 transcript
was expressed. In the skin, 12 CA genes were expressed
(Supplementary Table 2). Of these, CA4 had one of the lowest
levels of expression, with a normalized FPKM value of 160.18.
In neutrophils, the CA4 expression level was signiﬁcantly
higher than that in skin, with a FPKM of 7162.48. CA9 was
signiﬁcantly expressed in ﬁbroblasts, skin, and macrophages
(Figure 3), with signiﬁcantly higher expression in ﬁbroblasts
compared with the other tissues.
Characterization of the CA4 promoter
The unexpected and high-level induction of CA4 mRNA in the
skin wound prompted us to characterize the CA4 promoter in
detail to provide clues regarding the potential regulation of its
transcription. Our comparative genomics analysis of the
aligned CA4 promoter regions of 15 mammal species revealed
a distinct cluster of high scoring and well-conserved potential
transcription factor-binding sites immediately upstream of
a similarly predicted TATA-binding protein-binding site
(Figure 4). All 15 species presented a strong signal for
a CTCF-binding site located from − 55 to − 44 bp upstream
of the TSS (Figure 4). In 13 of the species, including humans,
this region was an exact match for previously experimentally
determined CTCF-binding sites. Overlapping the probable
CTCF site were predicted binding sites for SP1, KLF4
and MZF1. The SP1 and MZF1 sites matched previously
experimentally determined sites in all 15 species, while
KLF4 had a match in 14 species. The binding locations were
− 55 to − 44 on the sense-strand (CTCF), − 50 to − 39 on the
anti-sense strand (SP1), − 47 to − 41 on the sense-strand
(MZF1), and − 49 to − 39 on the sense-strand (KLF4)
(Figure 4). Importantly, our results did not reveal any
HIF-1α-binding sites in the CA4 promoter.
GO analysis of biological processes associated with CA4 in
skin
Next, we wanted to understand the potential function of CA4
in skin wound healing and thus performed GO enrichment
analysis of biological processes associated with CA4 expression.
GO enrichment analysis of genes with a strong expression
correlation (X0.50) with CA4 in skin resulted in 40 terms that
were represented two-fold or higher in our set versus the
expected levels (Supplementary Table 3). The terms with the
highest over-representation in our set were strongly related to
immune cell recruitment. In addition, terms related to
angiogenesis, endocytosis, inﬂammation and ion homeostasis
were also over-represented.
Expression of Car4 is not induced by hypoxia in the pure
hypoxia-driven angiogenesis model
To explore whether hypoxia induced the expression of Car4
(rodent gene for CA IV protein) during wound healing,
we next employed a pure hypoxia-driven angiogenesis of
oxygen-induced retinopathy model. We could not detect any
induction of Car4 mRNA either by hypoxia at P12 or by
revascularization at P17, thus eliminating the possibility that
CA4 is a hypoxia inducible gene (Supplementary Figure 1).
Figure 1 mRNA expression of CA4 and CA9 during wound healing.
Skin excision wounds were generated in WT mice as described in
the Methods section. Normal skin and skin wound samples were
collected from unwounded mice and from mice killed at various
time points after wounding. The skin samples were processed for
qPCR analysis as described in the Methods. The results for all
enzymatically active CAs are shown as the mean± s.d. Animal
numbers: unwounded: n=2; day 2: n=2; day 3: n=2; day 5:
n=3; day 7: n=2; day 10: n=2; day 14: n=2.
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Expression and characterization of recombinant CA IV
To further explore the function of CA IV in skin wound
healing, we produced and puriﬁed recombinant CA IV enzyme.
CA IV is especially suitable for therapeutic applications because
it is an extracellular enzyme and has one of the highest
enzymatic activity levels among the CAs. In SDS gel electro-
phoresis, a major band was identiﬁed at 30 kDa that
represented full-length recombinant CA IV (Supplementary
Figure 2). The afﬁnity-puriﬁed CA IV enzyme had a speciﬁc
activity of 3000–4000 units per mg of pure enzyme.
Wound treatment with CA IV and acetazolamide
Next, we examined the effects of recombinant CA IV and
endogenously expressed CAs on wound healing, focusing on
the re-epithelialization obtained by keratinocyte migration
during the hypoxic phase of healing. Rodents wound closure
can occur via two different means: wound contraction or true
re-epithelialization.12 To alleviate wound contraction and to
explore re-epithelialization speciﬁcally, a special skin excision
wound model was employed, in which a round silicone splint
is sutured into the skin to ﬁrmly attach the underlying dermis
and subcutis.12
The wounded animals were divided into three groups
that received topically applied saline (control), recombinant
CA IV enzyme or CA inhibitor (azetazolamide) in Pluronic-127
gels.13 There were no differences in the wound size immediately
after wounding or in the size of the scab covering the wound at
the end of the treatment trial (Supplementary Figure 3). The
recombinant CA IV enhanced the wound re-epithelialization
(Figure 5). The epithelial tongues were signiﬁcantly longer in the
recombinant CA IV-treated wounds than in the control wounds
(Po0.0001) (Figure 5). We could not detect any differences in
the amount of granulation tissue produced in the wounds
among the three treatment groups (Figure 5).
DISCUSSION
Skin wound closure is achieved by re-epithelialization, that is,
the lateral migration of keratinocytes. This process occurs
mainly under hypoxia, but its stimuli are poorly understood.
The present study shows that mRNA expression of two
members of the CA family, CA IV and IX, are increased
during the early phase of wound healing, and the cells
expressing the CAs form a band-like structure just underneath
the migrating epidermis in the healing skin wound. Further-
more, we demonstrate that exogenous application of recombi-
nant Car4 enzyme accelerates wound re-epithelialization
during the hypoxic phase of wound healing.
In hypoxic tissues, such as fast-growing cancers and wounds,
metabolic processes produce large amounts of both lactic acid
and carbon dioxide. CAs are enzymes that convert carbon
dioxide and water to bicarbonate and protons.3–5 Because the
intracellular pH must remain stable, all excess acidity is
efﬁciently exported from the cells, which in turn acidiﬁes the
extracellular environment to provide a favorable environment
for cancer cell migration and invasion.25 CAs have been linked
to this process in reports showing a CA inhibitor-induced
reduction of cancer cell invasion in contrast to a facilitation of
cancer cell migration and invasion by CA expression.25 CA IX,
in turn, is unique in the sense that it can stimulate cell
migration independent of extracellular acidiﬁcation.26,27
Namely, it can enhance cell migration by weakening cell
adhesions26,27 as well as by stimulating Rho-GTPase dependent
cell motility.26 In our study, CA IX expression persisted in the
Figure 2 Protein expression of Car4 and Car9 during wound
healing. Skin excision wounds were generated in WT mice as
described in the Methods section. Normal skin and skin wound
samples were collected from unwounded mice and from mice killed
at various time points after wounding. The skin samples were
processed for IHC analysis, and CA IV and CA IX were detected
using speciﬁc antibodies as described in the Supplementary
Methods. The results obtained at all studied time points are shown.
CA IV protein expression started to accumulate in the early
granulation tissue at day 5 of healing, and positive expression
remained in the wound until day 10, after which the expression
disappeared. CA IV protein was expressed mainly by the cells in
granulation tissue, with especially strong expression just beneath
the migrating epidermis (arrows). CA IX protein expression, in turn,
was already detected in the skin wound at day 2 and remained
elevated throughout the wound healing process. Animal numbers:
all time points: n=6 mice with two wounds; total n=12.
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migrating epidermis throughout the healing process, whereas
the expression of CA IV disappeared substantially earlier. The
strong expression of CA IX observed in the migrating
epidermis long beyond the hypoxic phase could be related to
its capability to stimulate cell migration independently of
acidiﬁcation of the hypoxic environment, and may be stimu-
lated by hepatocyte growth factor under normoxic
conditions.27
Figure 3 Expression of CA4 and CA9 in wound-related cells. RNA-Seq data for multiple immune and wound-healing-related cells was
retrieved from experiments performed using the ArrayExpress database and mapped to the genomic locations of all CA genes using Tophat.
The reads were then merged using Cuffmerge, and differential expression was determined using Cuffdiff. Finally, the results were
manipulated using the R package cummeRbund and visualized in R. Expression abundance measurements are represented on the y axis
as normalized fragments per kilobase of transcript per million mapped reads (FPKM) for CA4 (a) and CA9 (b).
Figure 4 Comparative genomics analysis of the CA4 promoter. An alignment of 15 mammalian sequences corresponding to the promoter of
the full-length human CA4 transcript ENST00000300900 was analyzed for putative transcription factor-binding sites by comparative
genomics. The 10 best scoring transcription factors were included in the ﬁgure, where height indicates the number of species supporting that
prediction. A positive y axis result indicates a TFBS predicted on the sense strand, while the negative y axis indicates the anti-sense strand.
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Of the two CAs that showed enhanced expression during
wound healing, CA IX is known to be induced by hypoxia. It
has a hypoxia-response element in its promotor region and is
one of the known target genes for hypoxia inducible factor-1α
(HIF-1α).3,4 Strikingly, the expression of CA IV was substan-
tially higher than CA IX at the mRNA level during hypoxia in
the skin wound. The expression of CA IV is usually reduced in
tumors,28 and the present results show that it does not possess
a classical hypoxia-response element in its promoter region for
HIF-1α binding. We further employed a pure hypoxia-driven
angiogenesis model in the retina and could not detect any
changes in the expression of Car4 by varying the oxygen levels.
Our results, in essence, eliminate the possibility that hypoxia is
responsible for the induction of Car4 expression.
Comparative genomics prediction of potential transcription
factor-binding sites in the promoter of the primary human
CA4 transcript ENST00000300900 revealed some high-scoring
candidates that may alter the expression of this protein.
In particular, there is a cluster of well-conserved binding
sites for KLF4, SP1 and MZF1, all of which were positioned
near a similarly conserved CTCF-binding site. CTCF is a well-
established contributor to the chromatin conﬁguration and
gene transcription across the genome,29 and thus its presence
and proximity provide greater weight to the other proximal
predictions. Furthermore, CTCF also promotes wound
healing.30 MZF1 is involved in myeloid cell differentiation31
and is a strong enhancer of cell migration and invasion,32 thus
potentially explaining the origin of the strong CA4 expression
in neutrophils. KLF4, in turn, has been shown to be expressed
during inﬂammation33 and wound healing34–37, and to facil-
itate cutaneous wound healing.36
Our RNA-Seq analysis revealed low levels of CA4 RNA in
normal skin and high levels in neutrophils. This ﬁnding implies
that the observed elevation of CA4 mRNA and protein in our
experiments may be due to the recruitment of neutrophils to
the wound site, which is consistent with the ﬁnding that
abundant neutrophil extravasation occurs in skin wounds
rapidly after wounding.
The few neutrophils that persist in the wound are known to
form a band-like structure immediately beneath the migrating
epidermis,38 a pattern that is strikingly similar to the expression
of CA IV. Despite long being considered detrimental for tissue
regeneration in general, especially during the early phase of
healing, neutrophils are currently considered crucial for skin
wound healing and tissue regeneration.39 Speciﬁcally, neutro-
phils that survive in the injured tissue for a long period of time
are crucial for tissue regeneration.40,41 Interestingly, neutrophils
require an acidic extracellular environment to be properly
activated and to prolong their functional life span, that is,
avoid apoptosis.42,43 Furthermore, excessive, early neutrophil
apoptosis (NETosis) has, in turn, been shown to retard diabetic
wound healing in both mice and humans,40 while proper
wound healing can be rescued in diabetes by the inhibition of
early NETosis, that is, keeping neutrophils alive and prolonging
their lifespan.40 This phenomenon could speciﬁcally explain
why neutrophils express an extracellular member of the
Figure 5 Accelerated re-epithelialization during wound healing in mice treated with recombinant Car4 enzyme. Mice with full-thickness
skin excision wounds were treated with either recombinant Car4 enzyme or CA inhibitor applied topically to the wound immediately after
wounding. Scars were harvested on day 5, and the re-epithelialization (a) and cross-sectional area of the granulation tissue (b) of the
wounds were quantiﬁed by examining two microscopic sections from each wound. The results are expressed as the average of the two
values. There were ﬁve animals, each with two wounds, in every treatment group. *Po0.05; analysis of variance. The results are expressed
as the mean± s.d., n=10 wounds. (c) Representative sections from wounds treated with recombinant CAIV or CA inhibitor and collected
on day 5 after wounding are shown for re-epithelialization. Scale bars, 600 μm low magniﬁcation, 240 μm high magniﬁcation.
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CAs, CA IV, which is crucial for extracellular acidiﬁcation.5
Especially strong production of CA IV and IX just beneath the
migrating epidermis suggests that these enzymes could generate
an acidic ‘micro-environment’ within healing wound tissue to
selectively aid not just neutrophil survival and function but also
keratinocyte migration, that is, closure of the wound.
Concerning CA IX expression in the skin wound, RNA-Seq
analysis conﬁrmed the expression of CA9 mRNA only in
ﬁbroblasts and skin, with signiﬁcantly higher expression in
ﬁbroblasts. The CA IX protein has been shown to be
upregulated in tumor ﬁbroblasts undergoing hypoxia,44,45
while ﬁbroblast-derived HIF-1α has been shown to be crucial
for wound healing.46
Based on the expression pattern of CA family members, we
conclude that CAs IV and IX are responsible for maintaining
the pH balance during skin wound healing. We were able to
observe the induction of CA IV and CA IX mRNAs during the
early hypoxic phases of wound healing, and both mRNAs
returned to the same level as the normal skin in 7 days. This
ﬁnding implies that there is a rapid induction of these proteins
in response to hypoxia (HIF1α-mediated for CA IX) and
inﬂammation (CA IV).
To understand the function of CAs in tissue regeneration
in general, we treated skin wounds with recombinant human
CA IV enzyme and with a clinically used CA inhibitor to block
the endogenous CA activity. The CA IV enzyme is especially
suitable for pharmaceutical studies because it is an extracellular
enzyme with one of the highest enzymatic activity levels
among the CAs.5,47 We could detect accelerated wound
re-epithelialization with recombinant CA IV, but blocking
the activity of endogenously expressed CA had no signiﬁcant
effect on wound re-epithelialization. This discrepancy is most
probably explained by the fact that endogenous CA accumula-
tion in the skin wound starts at least a few days after the
wounding. Thus, the CA inhibitor was unlikely to encounter
any enhanced CA protein expression during the majority of
our study period (days 0–5), whereas the addition of exogenous
recombinant CA enzyme provided a clear beneﬁt over
endogenous enzyme because it was present in the wound
immediately after wounding. This result is highly relevant for
CA4 because our data indicate that its primary source in the
wound bed is neutrophils, which begin to extravasate to the
wound within minutes after injury and are crucial for wound
healing but also require extracellular acidiﬁcation to prolong
their survival, which in turn is crucial for the proper progres-
sion of wound healing. Furthermore, closure of the wound by
keratinocyte migration starts immediately after wounding.
Immediate acidiﬁcation of the extracellular milieu by exogen-
ous CA4 should provide a boost for keratinocyte migration
during the early stages of healing.
Future studies are warranted to address whether CAs can be
used to stimulate tissue regeneration during injury-induced
hypoxia. CA IV may participate in promoting tissue regenera-
tion by generating an acidic ‘micro-environment’ for
neutrophils to survive and for the migrating epidermis to close
the wound during the hypoxic phase of wound healing.
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